Mehmet Muhittin YALÇIN, Nalan AKYÜREK, Aydın YAVUZ, Kürşat DİKMEN, Hasan BOSTANCI, Murat AKIN, Ahmet Çağrı BÜYÜKKASAP

Eleven patients with primary thyroid lymphoma: a single center experience

Background/aim: Primary thyroid lymphoma (PTL) is a very rare thyroid malignancy. It should be diagnosed and treated immediately and accurately. Our aim was to evaluate the diagnostic methods and treatment results for patients with PTL. Materials and methods: We retrospectively evaluated the records of 11 patients with PTL from 2009 to 2015, diagnosed at our institute. Age, sex, stage, histopathologic type, presence of Hashimoto s thyroiditis, diagnostic methods, treatment types, and recurrence were examined. Results: Six patients were female, 5 were male, and the median age of the patients was 61 years (range: 15 76 years). All patients had a large palpable mass in the neck. Fine needle aspirate (FNA) biopsy was performed in all patients; however, it was useful only in the diagnosis of 7 patients. Excisional and surgical biopsy was performed in 4 patients. All patients had non-Hodgkin B-cell lymphoma, including 9 cases of diffuse large B-cell lymphoma (DLBCL), and 2 patients had mucosa-associated lymphoid tissue (MALT) lymphoma. Recurrence was observed in one patient. Median survival was 34 months. Conclusions: The preferred option for the diagnosis of PTL should be FNA biopsy, and the treatment should be decided on according to whether the disease is limited to the thyroid gland or not, its histological type, and its stage.

PDF

___

1. Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol 2004; 5: 307-313.
2. Cheng V, Brainard J, Nasr C. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimotos thyroiditis. Thyroid 2012; 22: 647-650.
3. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000; 24: 623-639.
4. Vigliar E, Caleo A, Vitale M, DiCrescenzo V, Garzi A, Zeppa P. Early cytological diagnosis of extranodal stage I, primary thyroid non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature. BMC Surg 2013; 13: 49.
5. Chai YJ, Hong JH, Koodo H, Yu HW, Lee JH, Kwon H, Kim SJ, Choi JY, Lee KE. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study. Ann Surg Treat Res 2015; 89: 295-299.
6. Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery 2009; 146: 1105-1115.
7. Guastafierro S, Falcone U, Celentano M, Ferrara MG, Sica A, Carbone A, Rossiello R. Primary mantle cell lymphoma of the thyroid. Leuk Res 2010; 34: 548-550.
8. Koida S, Tsukasaki K, Tsuchiya T, Harasawa H, Fukushima T, Yamada Y, Ohshima K, Kamihira S, Kikuchi S, Tomonage M. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica 2007; 92: 37-40.
9. Thieblemont C, Mayer A, Dumontet C, Barbier Y, CalletBauchu E, Felman P, Berger F, Ducottet X, Martin C, Salles G et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002; 87: 105-111.
10. Yang H, Li J, Shen T. Primary T-cell lymphoma of the thyroid: case report and review of the literature. Med Oncol 2008; 25: 462-466.
11. Yang L, Wang A, Zhang Y, Mu Y. 12 cases of primary thyroid lymphoma in China. J Endocrinol Invest 2015; 38: 739-744.
12. Alzouebi M, Goepel JR, Horsman JM, Hancock BW. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol 2012; 40: 2075-2080.
13. Matsuda M, Sone H, Koyama H, Ishiguro S. Fine-needle aspiration cytology of malignant lymphoma of the thyroid. Diagn Cytopathol 1987; 3: 244-249.
14. Walsh S, Lowery AJ, Evoy D, McDermott EW, Prichard R. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist 2013; 18: 994-1003.
15. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkins disease staging classification. Cancer Res 1971; 31: 1860-1861.
16. Fujita A, Tomita N, Fujita H, Motohashi K, Hyo R, Yamasaki E, Hattori M, Fujisawa S, Kanamori H, Ogawa et al. Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 2009; 26: 49-54.
17. Pedersen RK, Pedersen NT. Primary non-Hodgkins lymphoma of the thyroid gland: a population based study. Histopathology 1996; 28: 25-32.
18. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604.
19. Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka K, Kuma K, Tominaga S. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985; 76: 1085-1090.
20. Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab 2013; 98: 3131-3138.
21. Kumar R, Khosla D, Kumar N, Ghoshal S, Bera A, Das A, Sharma SC. Survival and failure outcomes in primary thyroid lymphomas: a single centre experience of combined modality approach. J Thyroid Res 2013; 2013: 269034.
22. Pasieka J. Hashimotos disease and thyroid lymphoma: role of the surgeon. World J Surg 2000; 24: 966-970.
23. Sharma A, Jasim S, Reading CC, Ristow KM, Villasboas Bisneto JC, Habermann TM, Fatourechi V, Stan M. Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study. Thyroid 2016; 26: 1061-1067.
24. Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US features of thyroid malignancy: pearls and pitfalls. Radiographics 2007; 27: 847-860.
25. Triantafillou E, Papadakis G, Tzaida O, Papazian M, Megalakaki A, Moustakas K, Keramidas I, Kaltzidou V, Tertipi A, Pappas A. Primary thyroid lymphoma: the two ends of the spectrum. J BUON 2015; 20: 1164-1168.
26. Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 2007; 31: 978- 986.
27. Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Suguwara M. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993; 3: 93-99.
28. DiBiase SJ, Grigsby PW, Guo C, Lin HS, Wasserman TH. Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 2004; 27: 178-184.
29. Doria R, Jekel JF, Cooper DL. Thyroid lymphoma: the case for combined modality therapy. Cancer 1994; 73: 200-206.
30. Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg 1999; 33: 1-27.
31. Pyke CM, Grant CS, Habermann TM, Kurtin PJ, van Heerden JA, Bergstralh EJ, Kunselman A, Hay ID. Non-Hodgkins lymphoma of the thyroid: is more than biopsy necessary? World J Surg 1992; 16: 604-609.
32. Sippel RS, Gauger PG, Angelos P, Thompson NW, Mack E, Chen H. Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 2002; 9: 907-911.
33. Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg 1999; 126: 1199- 1204.
34. Wirtzfeld DA, Winston JS, Hicks WLJ, Loree TR. Clinical presentation and treatment of non-Hodgkins lymphoma of the thyroid gland. Ann Surg Oncol 2001; 8: 338-341.
35. Keating GM. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma. Drugs 2010; 70: 1445-1476.
36. Gao G, Liang X, Jiang J, Zhou X, Huang R, Chu Z, Zhan Q. A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkins lymphoma. Acta Oncologica 2010; 49: 3-12.
37. Stathis A, Ghielmini M. New agents for the treatment of lymphoma. Ann Oncol 2012; 23 Suppl 10: x92-x98.